Health

Sleep — we all need it, but most people aren’t getting enough of it. Ideally, we spend about a third of our lives asleep. When we’r ...

For a Philadelphia physician, rest seemed out of the question during the early part of the pandemic. But she learned an important lesson about the need to slow down.

Canyon Atlantic Partners LLC is asking a Chester County judge to put a pause on Tower Health’s closure of Brandywine and Jennersville hospitals.

The mandate is first taking effect first in jurisdictions that didn’t challenge the requirement in court.

The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.

COVID-19 numbers are down 75% from two weeks ago, suggesting the winter surge has peaked. But the pandemic is not over, officials warn.

With the Children’s Hospital of Philadelphia’s Center City location often 90% full, the new hospital in Montco is expected to add capacity as demand for beds increases.

Cases, hospitalizations, and positivity rates have fallen precipitously over the last two weeks, but still are well above last January’s previous peak.

The Chester County Health Department has asked schools to stop contact tracing and to focus on checking students for symptoms, testing them, and sending them home.

Measurements at age 1 showed faster brain activity in key regions in infants whose families received $300-plus each month. That's compared to infants in families who got $20.

COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.

The FDA said it was revoking emergency authorization for the drugs from Regeneron and Eli Lilly because they don't work against the omicron variant.

City health officials announced earlier this year they had given out more than 260,000 booster doses since August. This is how the numbers break down.

All those new positive cases means a shift in priorities, as CDC guidelines also have shifted.

Omicron’s resistance to the two leading monoclonal antibody medicines has upended the treatment playbook for COVID-19 in recent weeks.